These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11885931)
1. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells. Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931 [TBL] [Abstract][Full Text] [Related]
2. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Carroll MW; Moss B Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593 [TBL] [Abstract][Full Text] [Related]
3. High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara. Hebben M; Brants J; Birck C; Samama JP; Wasylyk B; Spehner D; Pradeau K; Domi A; Moss B; Schultz P; Drillien R Protein Expr Purif; 2007 Dec; 56(2):269-78. PubMed ID: 17892951 [TBL] [Abstract][Full Text] [Related]
4. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)]. Ferrer MF; Zanetti FA; Calamante G Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847 [TBL] [Abstract][Full Text] [Related]
5. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara. Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873 [TBL] [Abstract][Full Text] [Related]
7. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis. Ramsey-Ewing A; Moss B Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109 [TBL] [Abstract][Full Text] [Related]
8. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells. Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347 [TBL] [Abstract][Full Text] [Related]
9. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters]. Loparev VN; Chernos VI Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696 [TBL] [Abstract][Full Text] [Related]
10. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene. Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926 [TBL] [Abstract][Full Text] [Related]
12. Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain. Spehner D; Drillien R; Proamer F; Houssais-Pêcheur C; Zanta MA; Geist M; Dott K; Balloul JM Virology; 2000 Jul; 273(1):9-15. PubMed ID: 10891402 [TBL] [Abstract][Full Text] [Related]
13. [Expression of IL-6 in recombinant non-replicating vaccinia virus and studying its effects on immunogenicity]. Guo F; Lu R; Sun Z; Ma H; Li J; Zhang Y; Ma D; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):136-41. PubMed ID: 12196824 [TBL] [Abstract][Full Text] [Related]
14. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use. Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of replication-deficient vaccinia virus/T7 RNA polymerase hybrid expression: effect of T7 RNA polymerase levels and alpha-amanitin. Engleka KA; Lewis EW; Howard BH Virology; 1998 Apr; 243(2):331-9. PubMed ID: 9568032 [TBL] [Abstract][Full Text] [Related]
16. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Sutter G; Moss B Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287 [TBL] [Abstract][Full Text] [Related]
17. Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain. Suter M; Meisinger-Henschel C; Tzatzaris M; Hülsemann V; Lukassen S; Wulff NH; Hausmann J; Howley P; Chaplin P Vaccine; 2009 Dec; 27(52):7442-50. PubMed ID: 19539582 [TBL] [Abstract][Full Text] [Related]
18. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture. Bárcena J; Blasco R Virology; 1998 Apr; 243(2):396-405. PubMed ID: 9568038 [TBL] [Abstract][Full Text] [Related]
19. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara. Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798 [TBL] [Abstract][Full Text] [Related]
20. Modified vaccinia virus Ankara as a vector for suicide gene therapy. Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]